ES2196180T3 - Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada. - Google Patents

Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada.

Info

Publication number
ES2196180T3
ES2196180T3 ES96933878T ES96933878T ES2196180T3 ES 2196180 T3 ES2196180 T3 ES 2196180T3 ES 96933878 T ES96933878 T ES 96933878T ES 96933878 T ES96933878 T ES 96933878T ES 2196180 T3 ES2196180 T3 ES 2196180T3
Authority
ES
Spain
Prior art keywords
sustained release
narcotics
analgesics
antagonists
supply system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96933878T
Other languages
English (en)
Spanish (es)
Inventor
Alan Drizen
Peter Rothbart
Gary M Nath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LAM PHARMACEUTICAL CORP
Original Assignee
LAM PHARMACEUTICAL CORP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27415224&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2196180(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/630,205 external-priority patent/US5716631A/en
Application filed by LAM PHARMACEUTICAL CORP filed Critical LAM PHARMACEUTICAL CORP
Application granted granted Critical
Publication of ES2196180T3 publication Critical patent/ES2196180T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES96933878T 1995-09-29 1996-09-25 Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada. Expired - Lifetime ES2196180T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53675095A 1995-09-29 1995-09-29
US58827296A 1996-01-18 1996-01-18
US08/630,205 US5716631A (en) 1995-09-29 1996-04-10 Long acting narcotic analgesics and antagonists

Publications (1)

Publication Number Publication Date
ES2196180T3 true ES2196180T3 (es) 2003-12-16

Family

ID=27415224

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96933878T Expired - Lifetime ES2196180T3 (es) 1995-09-29 1996-09-25 Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada.

Country Status (7)

Country Link
EP (1) EP0859597B1 (enExample)
AT (1) ATE236616T1 (enExample)
AU (1) AU7244696A (enExample)
CA (1) CA2233280A1 (enExample)
DE (1) DE69627365T2 (enExample)
ES (1) ES2196180T3 (enExample)
WO (1) WO1997011681A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
US5897880A (en) * 1995-09-29 1999-04-27 Lam Pharmaceuticals, Llc. Topical drug preparations
US6251436B1 (en) 1995-09-29 2001-06-26 L.A.M. Pharmaceutical Corporation Drug preparations for treating sexual dysfunction
US5900420A (en) * 1997-06-19 1999-05-04 Cole; William L. Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form
US20020177626A1 (en) 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
DE10153673B4 (de) 2001-06-18 2005-04-07 Native Instruments Software Synthesis Gmbh Automatische Erzeugung von musikalischen Scratch-Effekten
DE10358749A1 (de) * 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Darreichungsform zur Bekämpfung von primären Kopfschmerzen
US9155734B2 (en) 2012-03-07 2015-10-13 Mallinckrodt Llc Stability of hydromorphone hydrochloride solutions
JP6074442B2 (ja) * 2012-03-07 2017-02-01 マリンクロッド エルエルシー 塩酸ヒドロモルホン液剤の改良された安定性
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
IT201800001890A1 (it) * 2018-01-25 2019-07-25 Fidia Farm Spa Composizioni farmaceutiche per il trattamento del dolore postoperatorio

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
EP0516026A1 (en) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel and method of producing same
US5356629A (en) * 1991-07-12 1994-10-18 United States Surgical Corporation Composition for effecting bone repair

Also Published As

Publication number Publication date
EP0859597A1 (en) 1998-08-26
EP0859597B1 (en) 2003-04-09
EP0859597A4 (enExample) 1998-10-07
DE69627365T2 (de) 2004-02-12
WO1997011681A1 (en) 1997-04-03
CA2233280A1 (en) 1997-04-03
ATE236616T1 (de) 2003-04-15
DE69627365D1 (de) 2003-05-15
AU7244696A (en) 1997-04-17

Similar Documents

Publication Publication Date Title
ES2196180T3 (es) Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada.
GR960100179A (el) Συσκευη διαδερμικης χορηγησης των φεντανιλ και σουφεντανιλ με ηλεκτρομεταφορα.
DK288987A (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
IL129410A (en) Unit dose, sustained release oral dosage form of an opioid analgesic and a method for the preparation thereof
NZ508808A (en) 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
ATE324872T1 (de) Orale pharmazeutische zusammensetzung mit verzögerter wirkstofffreigabe von protonenpumpen- hemmern
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
BR0010316A (pt) Método e sistema para obtenção de regimes de dosagem otimizados de epo para uma resposta farmacodinâmica/farmacocinética desejada em um paciente
NO982580D0 (no) Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene
NO20001829D0 (no) Forsinket total frigivelse av magetarmavleveringsmedikament
CY1114011T1 (el) Φαρμακευτικη στοματικη δοσολογικη μορφη που περιλαμβανει ενα συνδυασμο ενος οπιοειδους αγωνιστη και ενος οπιοειδους ανταγωνιστη
ATE548029T1 (de) Wirkstoffabgabevorrichtung mit verzögerter freisetzung
ATE270880T1 (de) Im magen verweilende mikrosphären mit gesteuerter freisetzung zur verbesserten arzneistoffabgabe
DE69720939D1 (de) Vorrichtung zur Abgabe von festen Arzneimitteln
YU59098A (sh) Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži
CA2239352A1 (en) Injectable quinolone formulations
BR9912827A (pt) Composições tópicas compreendendo um analgésico opióide e um antagonista de nmda
FI965021L (fi) Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa
FI973221L (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
GR1003095B (el) Συσκευη διαδερμικης χορηγησης των φεντανιλ και σουφεντανιλ με ηλεκτρομεταφορα.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
BRPI0012553B8 (pt) pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso
HU9700661D0 (en) Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
DE60004833D1 (de) Paracetamol und buspiron enthaltende pharmazeutische zusammensetzung mit analgetischer wirkung